| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.085 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |